The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Abstract
BACKGROUND: This report compares the clinical characteristics, epidemiologic investigations, infection-control evaluations, and microbiologic findings of all 7 of the cases of vancomycin-resistant Staphylococcus aureus (VRSA) infection in the United States during the period 2002-2006. METHODS: Epidemiologic, clinical, and infection-control information was collected. VRSA isolates underwent confirmatory identification, antimicrobial susceptibility testing, pulsed-field gel electrophoresis, and typing of the resistance genes. To assess VRSA transmission, case patients and their contacts were screened for VRSA carriage. RESULTS: Seven cases were identified from 2002 through 2006; 5 were reported from Michigan, 1 was reported from Pennsylvania, and 1 was reported from New York. All VRSA isolates were vanA positive and had a median vancomycin minimum inhibitory concentration of 512 microg/mL. All case patients had a history of prior methicillin-resistant S. aureus and enterococcal infection or colonization; all had several underlying conditions, including chronic skin ulcers; and most had received vancomycin therapy prior to their VRSA infection. Person-to-person transmission of VRSA was not identified beyond any of the case patients. Infection-control precautions were evaluated and were consistent with established guidelines. CONCLUSIONS: Seven patients with vanA-positive VRSA have been identified in the United States. Prompt detection by microbiology laboratories and adherence to recommended infection control measures for multidrug-resistant organisms appear to have prevented transmission to other patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Development of high-level vancomycin resistance in S. aureus (vancomycin-resistant S. aureus, VRSA) was first described in 2002 and was the result of acquisition by an MRSA strain of the vanA gene cluster from a VRE (E. faecalis) isolate (79).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,466
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,243
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
McDougal, L. K., Steward, C. D., Killgore, G., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,410
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Self-citationNoble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90528-v · Cited by 935
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 909
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587
Flagged first, then by citations
1 of the 33 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- WENZEL, 1982, Annals of Internal Medicine, 97, 440, 10.1059/0003-4819-97-3-440 · DOI
- WATANAKUNAKORN, 1982, Annals of Internal Medicine, 97, 376, 10.1059/0003-4819-97-3-376 · DOI
- Noble, 1992, FEMS Microbiology Letters, 72, 195, 10.1111/j.1574-6968.1992.tb05089.x · DOI
- 1997, MMWR. Morbidity and mortality weekly report, 46, 624
- 2004, MMWR. Morbidity and mortality weekly report, 53, 322
- 2007, MMWR. Morbidity and mortality weekly report, 56, 197
- SARAVOLATZ, 1982, Annals of Internal Medicine, 97, 325, 10.1059/0003-4819-97-3-325 · DOI
Cited by
Sorted by citations
Items 301–400 of 483
Antibody-Recruiting Small Molecules: Synthetic Constructs as Immunotherapeutics
McEnaney, P. J., Parker, C. G., & Zhang, A. X. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.08.008 · Cited by 11
Göktaş, S., Kurtoğlu, M. G., Sakarya, Y., Uğurluoğlu, C., Özçimen, M., Sakarya, R., Alpfidan, İ., Ivacık, I. S., Erdoğan, E., & Bukus, A. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0052 · Cited by 11
Diagnosis and management of community-associated MRSA infections in children
Long, C. B., Madan, R. P., & Herold, B. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.127 · Cited by 11
Rossolini, G. M., Arena, F., & Pollini, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-39968-8_2 · Cited by 11
A case report of postoperative VRSA enteritis
Okada, N., Fujita, T., Kanamori, J., Sato, A., Horikiri, Y., Sato, T., Fujiwara, H., & Daiko, H. (2018) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2018.08.038 · Cited by 10
Marinelli, F., & Genilloud, O. (2013) · Springer eBooks · doi:10.1007/978-3-642-39968-8 · Cited by 10
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment
Lynch, J. P., & Zhanel, G. G. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2154654 · Cited by 10
Cogo, A., González-Ruiz, A., Pathan, R. B., & Hamed, K. A. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0074-x · Cited by 10
Infective endocarditis; report from a main referral teaching hospital in Iran.
Heydari, B., Karimzadeh, I., Khalili, H., Shojaei, E., & Ebrahimi, A. (2017) · PubMed Central · Cited by 10
Schultz, J. R., Costa, S. K., Jachak, G. R., Hegde, P. V., Zimmerman, M. D., Pan, Y., Josten, M., Ejeh, C., Hammerstad, T. A., Sahl, H. G., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01151 · Cited by 10
Denis, O., Rodriguez‐Villalobos, H., & Struelens, M. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00003-8 · Cited by 12
Taş, T., Küçükbayrak, A., Hakyemez, İ. N., Mengeloğlu, F. Z., Simavlı, H., Özyalvaçlı, G., & Erdurmuş, M. (2013) · Cornea · doi:10.1097/ico.0b013e3182912ffa · Cited by 10
Drudge, C. N., Krajden, S., Summerbell, R. C., & Scott, J. A. (2011) · Aerobiologia · doi:10.1007/s10453-011-9219-x · Cited by 10
Neto, A. M. B., Rabelo, M. A., Lima, J. L. D. C., Loibman, S. O., Leal, N. C., & Maciel, M. A. V. (2018) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0159-2017 · Cited by 9
Mechanism of action of the lantibiotics on the multidrug-resistant organisms
Chattopadhyay, A., Das, N., & Banerjee, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99141-4.00010-2 · Cited by 9
Ribeiro, I. S., Muniz, I. P. R., Galantini, M. P. L., Gonçalves, C. V., Lima, P. H. B., Silva, E. S., Silva, N. R., Rosa, F. C. S., Rosa, L. P., Costa, D. J., et al. (2023) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-023-00495-1 · Cited by 10
Kim, J., Kim, Y., Park, B.-I., Choi, N., & Kim, K. (2023) · Molecules · doi:10.3390/molecules29010037 · Cited by 9
Challenges in the microbiological diagnosis and management of hVISA infections
Cheong, J. W. S., Harris, P. N. A., Oman, K. M., & Norton, R. E. (2011) · Pathology · doi:10.1097/pat.0b013e3283464ca3 · Cited by 9
Devrim, F., Gülfidan, G., Gözmen, S., Demirağ, B., Oymak, Y., Yaman, Y., Oruç, Y., Yaşar, N., Apa, H., Bayram, N., et al. (2015) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2015.1212 · Cited by 9
A New Target for Staphylococcus aureus Associated With Keratitis
Suzuki, T. (2011) · Cornea · doi:10.1097/ico.0b013e3182282100 · Cited by 9
Vancomycin Resistance in Ocular Infections
Gupta, M., Durand, M. L., & Sobrin, L. (2011) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31822d67c7 · Cited by 10
Synthesis and antibacterial activity of C2-symmetric binaphthyl scaffolded amino acid derivatives
Robertson, M. J., Bremner, J. B., Coates, J. A. V., Deadman, J. J., Keller, P. A., Pyne, S. G., Somphol, K., & Rhodes, D. I. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.06.024 · Cited by 9
Wang, H., Lü, Y., Liu, L., Kim, S. W., Hooker, J. M., Fowler, J. S., & Tonge, P. J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.008 · Cited by 9
Microbial Resistance and Superbugs
Jones, L. S., & Howe, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397043-5.00015-3 · Cited by 9
Huang, V., & Eells, S. J. (2011) · Wiley eBooks · doi:10.1002/9781118063842.ch10 · Cited by 9
Périchon, B., & Courvalin, P. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_15 · Cited by 8
Nepal, N., Mahara, P., Subedi, S., Rijal, K. R., Ghimire, P., Banjara, M. R., & Shrestha, U. T. (2023) · Microbiology Insights · doi:10.1177/11786361231183675 · Cited by 8
Eltschkner, S., Kehrein, J., Le, T. A., Davoodi, S., Merget, B., Basak, S., Weinrich, J. D., Schiebel, J., Tonge, P. J., Engels, B., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00437 · Cited by 9
Significance of MRSA in nosocomial Infections
Bhat, J. A., & Tenguria, R. K. (2014) · Cited by 8
Glycopeptide-Resistance in Enterococci
Depardieu, F., & Courvalin, P. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_20 · Cited by 8
Pathogenesis of Staphylococcus aureus in Humans
Lu, T., & DeLeo, F. R. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch39 · Cited by 8
Naha, S. K., Arpon, M. E. I., Siddique, R. T., Ripa, F. R., Hasan, M. N., & Uddin, M. J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316939 · Cited by 7
Polilli, E., Ursini, T., Mazzotta, E., Sozio, F., Savini, V., D’Antonio, D., Barbato, M., Consorte, A., & Parruti, G. (2012) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-11-6 · Cited by 7
Browne, S., Bhatia, S., Sarkar, N., & Kaushik, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99866-6.00017-9 · Cited by 7
Rational Design of Gram-Specific Antimicrobial Imidazolium Tetramers To Combat MRSA
Yuan, Y., Shi, W., Li, R., Lim, D. S. W., Armugam, A., & Zhang, Y. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01248 · Cited by 7
Treatment of Resistant Bacterial Infections in Children: Thinking Inside and Outside the Box
Livni, G., & Ashkenazi, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4726-9_9 · Cited by 7
Ertem, G. T., Öztürk, B., Hatipoğlu, Ç. A., İPEKKAN, K., Erdem, F., Adiloğlu, A. K., & Tülek, N. (2013) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2012-33360 · Cited by 7
Clearance of Intravitreal Daptomycin in Uveitis-Induced Rabbit Model
Özçimen, M., Sakarya, Y., Özçimen, S., Sakarya, R., Göktaş, S., Iyısoy, M. S., Alpfidan, İ., & Erdoğan, E. (2014) · Current Eye Research · doi:10.3109/02713683.2014.941072 · Cited by 7
Both, A., Franke, G. C., Mirwald, N., Lütgehetmann, M., Christner, M., Klupp, E.-M., Campos, C. E. B., Büttner, H., Aepfelbacher, M., & Rohde, H. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.08.009 · Cited by 7
Huh, H. J., Jang, M., Seo, J. Y., Kim, J., Ki, C., Kim, J., & Lee, N. Y. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.1.76 · Cited by 6
A model of the complex response of Staphylococcus aureus to methicillin
Pienaar, E., Whitney, S. E., Viljoen, H. J., & van Rensburg, N. F. J. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.12.003 · Cited by 6
Coghlan, D. R., Bremner, J. B., Keller, P. A., Pyne, S. G., David, D. M., Somphol, K., Baylis, D. C., Coates, J. A. V., Deadman, J. J., Rhodes, D. I., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.013 · Cited by 6
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections
Beresford, E., Biek, D. P., Jandourek, A., Mawal, Y. R., Riccobene, T. A., & Friedland, H. D. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.884457 · Cited by 6
Bakthavatchalam, Y. D., Veeraraghavan, B., Ragupathi, N. K. D., Babu, P., Munuswamy, E., & David, T. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.12.008 · Cited by 6
Yamaguchi, T., Ando, R., Matsumoto, T., Ishii, Y., & Tateda, K. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s209591 · Cited by 6
Samanta, I., & Bandyopadhyay, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815770-1.00016-x · Cited by 6
Binaphthyl‐Based Dicationic Peptoids with Therapeutic Potential
Bremner, J. B., Keller, P. A., Pyne, S. G., Boyle, T. P., Brkić, Z., David, D. M., Garas, A. M. S., Morgan, J., Robertson, M., Somphol, K., et al. (2009) · Angewandte Chemie · doi:10.1002/ange.200904392 · Cited by 6
Assessment of linezolid prescriptions in three French hospitals
Dentan, C., Forestier, E., Roustit, M., Boisset, S., Chanoine, S., Épaulard, O., & Pavèse, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2900-4 · Cited by 6
McCarthy, M. W., Baker, T., Satlin, M. J., & Walsh, T. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-77674-3_15 · Cited by 6
Population Genetics ofStaphylococcus
Smyth, D. S., & Robinson, D. A. (2010) · Wiley eBooks · doi:10.1002/9780470600122.ch16 · Cited by 6
Characterization ofStaphylococcus aureusStrains Isolated from Veterinary Hospital
Stella, A. E., Lima, T., Moreira, C. N., & de Paula, E. M. N. (2020) · International Journal of Microbiology · doi:10.1155/2020/2893027 · Cited by 5
Salman, M., Eldin, A. I. Z., Eissa, N., Maher, A., Aish, A.-E., & El‐Moez, S. I. A. (2024) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2024.k778 · Cited by 5
Yılmaz, M., & Şeker, E. (2022) · Etlik Veteriner Mikrobiyoloji Dergisi · doi:10.35864/evmd.1008728 · Cited by 6
Huang, S., He, J., Zhang, Y., Su, L. H. J., Tong, L., Sun, Y., Zhou, M., & Chen, Z. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s370755 · Cited by 5
Manfredini, C., Picoli, S. U., & Becker, A. P. (2011) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442011000200008 · Cited by 5
Clinical pharmacology of linezolid: an oxazolidinone antimicrobial agent
Tan, T. Q., & Yogev, R. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.4.479 · Cited by 5
β-lactams against emerging ‘superbugs’: progress and pitfalls
Helfand, M. S. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.4.559 · Cited by 5
Antibiotic-resistant bacteria in wastewater and potential human exposure through wastewater reuse
Goldstein, R. E. R. (2013) · University Libraries (University of Maryland) · Cited by 5
Tenover, F. C., & Rasheed, J. K. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch32 · Cited by 5
Maîtrise des bactéries hautement résistantes aux antibiotiques émergentes (BHRe)
Fournier, S. (2014) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2014.03.003 · Cited by 4
The RM Test for Determining Methicillin-Resistant Staphylococcus aureus Lineages
Lindsay, J. A., & Sung, J. M.-L. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-279-7_1 · Cited by 4
Choopani, A., Golmohmmadi, R., Rafati, H., & Fooladi, A. A. I. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Glycopeptide Resistance in S. aureus
Mirza, H. C. (2017) · InTech eBooks · doi:10.5772/65471 · Cited by 4
Peer Comparison of Anti-MRSA Agent Prescription in the Inpatient Setting
Bork, J. T., Morgan, D. J., Heil, E. L., Pineles, L. L., & Kleinberg, M. E. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.219 · Cited by 4
Neue Impfstoffkonzepte auf Basis moderner Erkenntnisse der Immunologie
Kaufmann, S. H. E., Meinke, A. L., & von Gabain, A. (2009) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-009-0951-0 · Cited by 4
Vainio, A. (2012) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 4
Daptomycin versus Vancomycin in anEnterococcus faecalisEndophthalmitis Rabbit Model
Özçimen, M., Kurtoğlu, M. G., Göktaş, S., Ömeroğlu, E., Sakarya, Y., Alpfidan, İ., Özçimen, S., Sakarya, R., Yener, H. İ., Demir, L. S., et al. (2015) · Current Eye Research · doi:10.3109/02713683.2015.1004722 · Cited by 4
Rosé, L., Chan, S., Hossain, J., & Pentima, M. C. D. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00768-13 · Cited by 4
Pathogenesis and Management of Dialysis Access Infections
Regunath, H., Ariyamuthu, V. K., & Chaudhary, K. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411629-0.00008-8 · Cited by 4
Yoshioka, N., Deguchi, M., Hagiya, H., Yoshida, H., Yamamoto, N., Hashimoto, S., Akeda, Y., & Tomono, K. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-017-2919-2 · Cited by 4
Hemodialysis-Associated Infections
Arduino, M. J., Patel, P. R., Thompson, N. D., & Favero, M. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00023-6 · Cited by 4
Festa, R. A., Cockerill, F. R., Pesano, R. L., Haley, E., Luke, N., Mathur, M., Chen, X., Havrilla, J. M., Percaccio, M., Rosas, A., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14111168 · Cited by 3
Xiao, Z., Xu, H., Wang, J., Hu, X., Huang, X., Song, S., Zhang, Q., Liu, Y., Liu, Y., Liu, N., et al. (2024) · FEMS Microbiology Letters · doi:10.1093/femsle/fnae072 · Cited by 3
Blocking the Spread of Resistance
Otto, M. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006128 · Cited by 3
Antibiotic resistance in lactococci and enterococci: phenotypic and molecular-genetic aspects
Plotnikava, D. T., Sidarenka, A. V., & Novik, G. I. (2017) · The EuroBiotech Journal · doi:10.24190/issn2564-615x/2017/01.03 · Cited by 3
Alkan, Y., Kaymaz, A., Behçet, M., & Bayrak, A. (2024) · Current Eye Research · doi:10.1080/02713683.2024.2349661 · Cited by 3
Antibiotic Consideration in Transplant Recipients
Altshuler, J., Aitken, S. L., Maslow, M. J., Papadopoulos, J., & Safdar, A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_50 · Cited by 3
Morales‐Cartagena, A. (2015) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v5.i2.14 · Cited by 3
HEALTH CARE–ASSOCIATED INFECTIONS
Huskins, W. C., & Goldmann, D. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50249-1 · Cited by 3
Fatima, T., Askri, Z. U. A., Shahid, M. H., Khan, A. Z., Asif, S., Ghumman, A. R., & Afzal, M. F. (2022) · Cureus · doi:10.7759/cureus.23212 · Cited by 3
Occupational MRSA Infection: Risk Factor, Disposition, Prevention, and Therapy
Brans, R., Kaup, O., & Schürer, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-40221-5_98-2 · Cited by 3
Treatment of Staphylococcal Infections
Crossley, K., & John, J. F. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch31 · Cited by 3
Lichens as Sources of Antibacterial Compounds
Es-sadeqy, Y., Chouati, T., Aoussar, N., Zalegh, I., Mhand, R. A., Rhallabi, N., & Mellouki, F. (2020) · Wiley eBooks · doi:10.1002/9781119593249.ch6 · Cited by 3
Zencir, M., Arı, A., Yılmaz, N., Avcı, M., Çalık, Ş., Coşkuner, S. A., Bal, F., & Ağuş, N. (2016) · ANKEM Dergisi · doi:10.5222/ankem.2016.018 · Cited by 2
Retrospective Analysis of Vancomycin Use in Febrile Neutropenic Patients
Duco, M. R., Przybylski, D. J., Cosimi, R. A., & Reeves, D. J. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000845 · Cited by 2
Development of a Spectrophotometric Assay for the Cysteine Desulfurase from Staphylococcus aureus
Sabo, E. T., Nelson, C. L., Tyagi, N., Stark, V., Aasman, K., Morrison, C. N., Boyd, J. M., & Holz, R. C. (2025) · Antibiotics · doi:10.3390/antibiotics14020129 · Cited by 2
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides
Artesani, L., Gallo, M. L., Giovati, L., Bisignano, F. M., Ferrari, E., Castronovo, L. M., Conti, S., Santoro, F., Pertinhez, T. A., & Ciociola, T. (2025) · Antibiotics · doi:10.3390/antibiotics14050437 · Cited by 3
Reischl, U., & Holzmann, T. (2008) · Journal of Laboratory Medicine · doi:10.1515/jlm.2008.034et · Cited by 2
Antibiotic Collateral Damage: Resistance and Antibiotic-Associated Diarrhea
Matsuura, G. T., & Garrison, M. W. (2011) · Hospital Pharmacy · doi:10.1310/hpj4610-758 · Cited by 2
Infection control of Staphylococcus aureus : spa typing to elucidate transmission
Mernelius, S. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-116703 · Cited by 2
He, M., Shao, L., Liu, Q., Li, J., Lin, H., Jing, L., Li, M., & Chen, D. (2016) · Letters in Applied Microbiology · doi:10.1111/lam.12583 · Cited by 2
La seconde vie de la daptomycine : analyse d’un « come back » réussi
Decousser, J., & Doucet‐Populaire, F. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(08)75150-3 · Cited by 2
Glycopeptide resistant enterococci: What's the problem?
Birgand, G. (2009) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2009.07.001 · Cited by 1
Thomas, C. A., Kim, C. K., El‐Araby, A. M., Birhanu, B. T., Nguyen, V. T., Schroeder, V. A., Fisher, J. F., Chang, M., & Mobashery, S. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00685 · Cited by 1
Efflux-Mediated Drug Resistance in Staphylococcus aureus
Kalia, N. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_13 · Cited by 1
Alvarado‐Gamarra, G., Alcalá-Marcos, K. M., Alvarado-Gamarra, P. K., & Merino, R. C. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Staphylococcus aureus: the “Superbug”
Otto, M. J. (2014) · ASM Press eBooks · doi:10.1128/9781555815479.ch16 · Cited by 1
Redmond, A., Donlon, S., Boyle, G., McCann, M., & Einarsdóttir, H. (2011) · Journal of Renal Care · doi:10.1111/j.1755-6686.2011.00216.x · Cited by 1
Multidrug-Resistant Bacteria: The Emerging Crisis
Livorsi, D. J., Stenehjem, E. A., & Gaynes, R. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4496-1_2 · Cited by 1
Isolation of vancomycin-resistant Staphylococcus aureus in a patient with burn injury
Ranjbary, A. G. (2015) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000061 · Cited by 1
Metadata
- Authors
- Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Corresponding author
- Sievert, D. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 46
- Issue
- 5
- Pages
- 668-674
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2023638940
- Cited by
- 483
- References
- 33
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 7 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 16 · 2019: 21 · 2018: 25 · 2017: 20 · 2016: 19 · 2015: 27 · 2014: 39 · 2013: 36 · 2012: 37
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- vancomycin-resistant Staphylococcus aureus, vanA gene, methicillin-resistant Staphylococcus aureus, enterococcal infections, human-to-human transmission, infection control, multidrug-resistant organisms, antimicrobial resistance, chronic skin ulcers, United States
- MeSH terms
- Adult, Aged, Bacterial Proteins, Carrier State, DNA, Bacterial, Family Health, Female, Genotype, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, United States, Bacterial Typing Techniques, Electrophoresis, Gel, Pulsed-Field, Infection Control, Carbon-Oxygen Ligases, Guideline Adherence, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
